Comprised of more than 70 innovative, internationally recognized basic and clinical researchers and active clinicians working in state-of-the-art facilities, our division’s contributions are validated through high-impact publications, strong federal and non-federal grant funding, and a robust clinical program that provides cutting-edge, comprehensive care across the spectrum of kidney disease. With advanced training and expertise, the APP focuses on subspecialized care, including chronic illness and disease management, ensuring continuity of care throughout the patient’s healthcare journey, which may span multiple years.